Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2022 | Important complications of SCD

Erfan Nur • 22 Mar 2022
EBMT 2022
Non-Malignant Sickle Cell Disease

Erfan Nur, MD, PhD, Amsterdam University Medical Center, Amsterdam, Netherlands, discusses complications in sickle cell disease (SCD). SCD is characterized by vaso-occlusive crisis and chronic anemia. In addition, due to intravascular hemolysis and microvascular occlusion leading to continuous oxidative stress, inflammation, and cellular damage, patients experience gradual complications in most vital organs, including the heart, the kidneys, the lungs, the liver, and the brain. This interview took place at the 48th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2022, which was held virtually.

Disclosures

Novartis: consultancy, ad board, research funding, speakers bureau; Roche: speakers bureau; Celgene: speakers bureau

More from Erfan Nur

3:41
ATG vs PTCy as GvHD prophylaxis in non-myeloablative MUD alloHSCT
Erfan Nur • 22 Mar 2022
3:12
An update on alloHSCT in SCD
Erfan Nur • 22 Mar 2022

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals